BioSpace News Archive

Genetown

Syndax Announces Participation at Two Upcoming Investor Conferences - Feb 28, 2022

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that members of its management team will participate in two upcoming investor conferences.

February 28, 2022

·

1 min read

Contact Lens Market: Surging Number of Eye-related Disorders Boosts Demand for Contact Lenses

The global contact lens market is projected to witness considerable rise owing to rising prevalence of increased preference for contact lenses over prescribed eyeglasses for aesthetics purposes and rising cases of vision related problems like myopia.

February 28, 2022

·

6 min read

Aesthetic Ultrasound Generators Market: Rise in Non-melanoma Skin Cancer Due to Environmental Factors Boosting Market

Aesthetics is one of the fastest growing segments of the medical devices industry.

February 28, 2022

·

5 min read

Advanced Glycation End Products Market: Non-fluorescent AGEs to Dominate Global Market

According to the report, the global advanced glycation end products market was valued at US$ 1.56 Bn in 2020.

February 28, 2022

·

8 min read

Business

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

Targovax ASA a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, announces that it has appointed Dr. Lubor Gaal as Chief Financial Officer, effective as of 7 March 2022.

February 28, 2022

·

2 min read

Drug Development

Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead of Phase 3 Trial

Bavarian Nordic A/S, a fully integrated vaccines company, announced additional positive results from a Phase 2 clinical trial of its non-adjuvanted COVID-19 vaccine candidate, ABNCoV2, which is being developed as a universal booster vaccine.

February 28, 2022

·

5 min read

Drug Development

Diadem Receives CE-IVD Certification to Market Its AlzoSure® Predict Prognostic Blood Test for the Early Prediction of Alzheimer’s Disease in Europe

Diadem Srl today announced CE IVD certification for its AlzoSure® Predict prognostic blood test for the early prediction of Alzheimer’s disease (AD).

February 28, 2022

·

4 min read

Deals

Myonex to Acquire Clinical Trial and Drug Wholesale Business of Hubertus in Berlin

Myonex, a leading global clinical trial supply company, announces entry into a definitive agreement with the owners of Hubertus Apotheke am Salzufer to acquire the Clinical Trial and Wholesale Drug Business, located in Berlin, Germany.

February 28, 2022

·

3 min read

Business

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical Update

Lexicon Pharmaceuticals, Inc. reported financial results for the three months and full-year ended December 31, 2021 and provided an update on key milestones.

February 28, 2022

·

8 min read

Business

Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Praxis Precision Medicines, Inc. provided a corporate update, including a video highlighting recent business and pipeline progress, and reported financial results for the fourth quarter and full year 2021.

February 28, 2022

·

13 min read